New Sheffield research could help to develop preventative treatments for heart disease

Heart

Researchers at the University of Sheffield are to study if ‘turning off’ a protein could help prevent heart attacks and strokes.

A team of scientists, led by Professor Paul Evans from the University of Sheffield’s Department of Infection, Immunity and Cardiovascular Disease, have been funded by the British Heart Foundation (BHF) to look at the role a protein called c-Rel plays in the development of atherosclerosis.

Atherosclerosis is a disease where fatty materials build up over time inside the walls of the arteries, forming a plaque. This build-up can eventually trigger rupture of the plaque leading to heart attacks and strokes.
As blood flows through our circulatory system, it creates friction on the wall of the blood vessels. In areas where blood vessels branch or bend, the complex pattern of blood flow and friction can damage vessel walls and make plaques more likely to form.

Previous research has shown that this damage also ‘switches on’ the protein c-Rel, accelerating the build-up of fatty plaques.

In this study, Professor Evans and his team will investigate how removing c-Rel affects the progression of the disease in mice. If mice lacking c-Rel are shown to have lower levels of build-up of these dangerous plaques, it could pave the way for developing drugs to block this protein and reduce a person’s risk of heart attack and stroke.

Professor Evans said: “Heart attacks and strokes are two of the leading causes of death and disability in the UK. That’s why it is vital that we look at new ways of preventing the development of atherosclerosis, the disease which lies behind these life-threatening conditions.

“With this BHF-funded project, we are aiming to prove a link between the protein c-Rel, and the formation of fatty plaques in the arteries. If we’re able to show that, it would identify a target for the development of medications to treat people considered at risk of heart attack and stroke.”
JimWaller

Jim Waller, a retired systems engineer from Sheffield, had a heart attack when he was just 49.

“I had just got back from walking my dogs near to my house. I had started to experience chest pain whilst I was out, and it gradually got worse and worse. It was probably the worst pain I’ve ever felt.

“When I called the emergency services, they went through all the symptoms with me – the pain, the tingling in my left arm, the nausea. I said I had all of them, so they advised me to open the front door and then to sit down and wait for the ambulance which would be there very soon.

“Once they had confirmed I was having a heart attack I was rushed to hospital, and I decided then and there that I definitely didn’t ever want to go through this again!

“I’ve done a lot to change my lifestyle since it happened, including giving up smoking, doing a lot more exercise and taking up meditation to reduce my stress levels. I have now been diagnosed with heart failure, which was caused by the damage to my heart during the heart attack.”

Mr Waller added: “Research that contributes to preventing heart attacks is very important. Although I was lucky enough to survive mine, the damage it has done to my heart is permanent, so finding treatments which could help others avoid this in future is crucial.”

BHF Research Advisor Lucie Duluc said: “In the UK there are over 100,000 hospital admissions due to heart attacks each year, so we urgently need to find new therapies to prevent them.
“There is still so much we don’t know about the development of atherosclerosis, so research like this is crucial to advance our knowledge and make lifesaving treatments a reality.

“Research like this has only been made possible by the generous funding of the public and their support to drive forward our mission to beat heartbreak forever.”

Additional information

The University of Sheffield

With almost 29,000 of the brightest students from over 140 countries, learning alongside over 1,200 of the best academics from across the globe, the University of Sheffield is one of the world’s leading universities.

A member of the UK’s prestigious Russell Group of leading research-led institutions, Sheffield offers world-class teaching and research excellence across a wide range of disciplines.

Unified by the power of discovery and understanding, staff and students at the university are committed to finding new ways to transform the world we live in.

Sheffield is the only university to feature in The Sunday Times 100 Best Not-For-Profit Organisations to Work For 2018 and for the last eight years has been ranked in the top five UK universities for Student Satisfaction by Times Higher Education.

Sheffield has six Nobel Prize winners among former staff and students and its alumni go on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.

Global research partners and clients include Boeing, Rolls-Royce, Unilever, AstraZeneca, Glaxo SmithKline, Siemens and Airbus, as well as many UK and overseas government agencies and charitable foundations.

Contact

For further information please contact: 

Emma Griffiths
Media and PR Assistant
The University of Sheffield
0114 222 1034
e.l.griffiths@sheffield.ac.uk